This study examines growth alterations in liver foci and tumor development as a basis for the different susceptibility in hepatocarcinogenes is found among different strains of mice. Male C57, B6C3F 1, and C3H mice treated with a single dose (1 mg/kg) of N,N-diethylnitrosamine (DEN) at 15 days of age and followed up to 12 months displayed a strain-dependent (C3H > B6C3F1 > C57) increase in incidence, number, volume fraction, and size of foci and macroscopic lesions (masses). DEN-treated mice exhibited a time-dependent increase in foci size but not in foci number. Phenobarbital (PB) treatment (500 ppm) in the drinking water starting 2 weeks after DEN-initiation did not affect the incidence or number of masses and foci. In all 3 strains, the bromodeoxyuridin e labeling index in foci correlated with foci growth, supporting the major role of cell proliferation in foci growth. Measurements of apoptosis by morphological criteria with H&E staining suggest that intrafocal apoptosis may be a late event preventing foci growth and possibly also promoting focal cell selection, whereas extrafocal apoptosis may facilitate clonal growth by removing adjacent normal cells. The onset of conversion of foci to masses also correlated with strain susceptibility to hepatocarcinogenesis .
Bennett LM, Winkler ML, Drinkwater NR (1993). A gene that determines the high susceptibility of the C3H/HeJ strain of mouse to liver tumor induction is located on chromosome one. Proc Amer AssocCancer Res34: 144.
2.
Bursch W., Paffe S., Putz B., Barthel G., Schulte-Hermann R. (1990). Determination of the length of the histological stages of apoptosis in normal and in altered hepatic foci of rats. Carcinogenesis11: 847— 853.
3.
Diwan BA, Rice JM, Ward JM, Oshima M., Lynch PH (1984). Inhibition of phenobarbital and lack of effect of amobarbital on the development of liver tumors induced by N-nitrosodiethylamine in juvenile B6C3F1 mice. Cancer Lett23: 223—234.
4.
Drinkwater NR, Bennett LM (1991). Genetic control of carcinogenesis in experimental animals. In: Modification of Tumor Development in Rodents, Ito N, Sugano H (eds). Vol. 33, Karger, Basel, pp 1—20.
5.
Drinkwater NR , Ginsler JJ (1986). Genetic control of hepatocarcinogene- sis in C57BL/6J and C3H/HeJ inbred mice. Carcinogenesis7(10): 1701— 1707.
6.
Gariboldi M. , Manenti G., Canzian F., Falvella FS, Pierotti MA, Della Porta G., Binelli G., Dragani TA (1993). Chromosome mapping of murine susceptibility loci to liver carcinogenesis. Cancer Res53: 209—211.
7.
Gold LS, Manley NB, Slone TH, Garfi nkel GB, Rohrbach L., Ames BN ( 1993). The fi fth plot of the carcinogenesis potency database results of animal bioassay published in the general literature through 1988 and by the National Toxicology Program through 1989. Environ Health Perspect100: 65—135.
8.
Gold LS, Slone TH, Manley NB, Bernstein L. (1991). Target organs in chronic bioassays of 533 chemical carcinogens. Environ Health Perspect93: 233—246.
9.
Goldsworthy TL, Conolly RB, Fransson-Steen R. (1996). Apoptosis and cancer risk assessment. Mutat Res365: 71—90.
10.
Goldsworthy TL, Fransson-Steen R., Maronpot RR (1996). Importance of and approaches to quantifi cation of hepatocyte apoptosis . Toxicol Pathol24: 24—35.
11.
Goldsworthy TL , Morgan KT, Popp JA, Butterworth BE (1991). Guidelines for measuring chemically-induced proliferation in specific rodent target organs. In: Chemically-Induced Cell Proliferation: Implications for Risk AssessmentButterworth BE, Slaga TJ (eds). Wiley-Liss, New York , pp 253—284.
12.
Goldsworthy TL , Romach EH, Fox TR (1999). Mouse liver carcinogenesis . In: Testing, Predicting and Interpreting Carcinogenicity . Kitchin KT (ed). Marcel Dekker, New York, pp 145—196.
13.
Grasl-Kraupp B., Bursch W., Rattkay-Nedecky B., Wagner A., Lauer B., Schulte-Hermann R. (1994). Food restriction eliminates preneoplastic cells through apoptosis and antagonizes carcinogenesis in rat liver. Proc Natl Acadc Sci USAA91: 9995—9999.
14.
Hanigan MH, Kemp CJ, Ginsler JJ, Drinkwater NR (1988). Rapid growth of preneoplastic lesions in hepatocarcinogen-sensitiv e C3H/HeJ mice relative to C57BL/6J male mice. Carcinogenesis9(6): 885— 890.
15.
Hanigan MH, Winkler ML, Drinkwater NR (1990). Partial hepatectomy is a promoter of hepatocarcinogenesi s in C57BL/6J mice but not in C3H/HeJ male mice. Carcinogenesis11(4): 589—594.
16.
Lee GH, Bennett LM, Carabeo RA, Drinkwater NR (1995). Identification of hepatocarcinogen-resistanc e genes in DBA/2 mice. Genetics139(1): 387— 395.
17.
Lee GH, Monura K., Kanda H., Kusakabe M., Yoshiba A., Sakakura T., Kitagawa T. (1991). Strain specific sensitivity to diethylnitrosamine-induce d carcinogenesis is maintained in hepatocytes of C3H/H3N↔C57BL/6N chimeric mice. Cancer Res51: 3257—3260.
18.
Lee GH, Nomura K., Kitagawa T. (1989). Comparative study of diethylinitrosamine-initiated two-stage hepatocarcinogenesi s in C3H, C57BL and BALB mice promoted by various hepatopromoters. Carcinogenesis10(12): 2227—2230.
19.
Lin ELC , Klaunig JE, Mattox JK, Weghorst CM, McFarland BH, Pereira MA (1989). Comparison of the effects of acute and subacute treatment of phenobarbital in different strains of mice . Cancer Lett48: 43—51.
20.
Manenti G., Binelli G., Gariboldi M., Canzian F., De Gregorio L., Falvella FS, Dragani TA, Pierotti MA (1994). Multiple loci affect genetic redisposition to hepatocarcinogenesi s in mice. Genomics23: 118—124.
21.
Maronpot RR , Haseman JK, Boorman GA, Eustis SE, Rao GN, Huff JE (1987). Liver lesions in B6C3F1 mice: The National Toxicology Program, experience and position. Arch Toxicol Suppl10: 10—26.
22.
Mills JJ, Chari RS, Boyer IJ, Gould MN, Jirtle RL (1995). Induction of apoptosis in liver tumors by the monoterpene perilyl alcohol. Cancer Res55: 979—983.
23.
Moser GJ, Wolf DC, Goldsworthy TL (1997). Quantitative relationship between transforming growth factor-alpha and hepatic focal phenotype and progression in female mouse liver. Toxicol Pathol25(3): 275—283.
24.
Nychka D., Pugh TD, King JH, Koen H., Wahba G., Chover J., Goldfarb S. (1984). Optimal use of sampled tissues sections for estimating the number of hepatocellular foci. Cancer Res44: 178—183.
25.
Pereira MA, Klaunig JE, Herren-Freund SL, Ruch RJ ( 1986). Effect of Phenobarbital on the development of liver tumors in juvenile and adult mice. J Natl Cancer Inst77(2): 449—452.
26.
Pitot HC (1990). Altered hepatic foci: Their role in murine hepatocarcinogenesis . Annu Rev Pharmacol Toxicol30: 465—500.
27.
Pitot HC, Dragan Y. (1993). Stage of tumor progression, progressor agents, and human risk. Proc Soc Exp Biol Med202: 37—43.
28.
Pugh TD, Goldfarb S. (1992). Growth kinetics of microscopic hepatocellular neoplasms in carcinogen-resistant and carcinogen-responsive strains of mice . Cancer Res52: 280—284.
29.
Pugh TD, King JH, Koen H., Nychka D., Chover J., Wahba G., He Y-H., Goldfarb S. (1983). Reliable stereological method for estimating the number of microscopic hepatocellular foci from their transections. Cancer Res43: 1261—1268.
30.
Satoh K., Hatayama I., Tateoka N., Tamai K., Shimizu T., Tatematsu M., Ito N., Sato K. ( 1989). Transient induction of single GST-P positive hepatocytes by DEN. Carcinogenesis10(11): 2107 —2111.
31.
Schulte-Hermann R., Bursch W., Kraupp-Grasl B., Oberhammer F., Wagner A., Jirtle R. (1983). Cell proliferation and apoptosis in normal liver and preneoplastic foci. Environ Health Perspect101(Suppl 5): 87—90.
32.
Schulte-Hermann R., Grasl-Kraupp B., Bursch W. (1995). Apoptosis and hepatocarcinogenesis . In Jirtle, RJ (ed). Liver Regeneration and Carcinogenesis Chapter 10, Academic Press, San Diego, CA , pp 141— 178.
33.
Schulte-Hermann R., Bursch W., Low-Baselli A., Wagner A., Grasl-Kraupp B. (1997). Apoptosis in the liver and its role in hepatocarcinogenesis . Cell Biol Toxicol13: 339—348.
34.
Seachrist L. (1996). Only the strong survive: the evolution of a tumor favors the meanest, most aggressive cells. Science News149: 216— 217.
35.
Stinchcombe S., Buchmann A., Boch KW, Schwarz M. (1995). Inhibition of apoptosis during 2,37,7,8-tetrachlorodibenzo-p-dioxin- mediated tumor promotion in rat liver. Carcinogenesis16: 1271— 1275.
36.
Thompson CB (1995). Apoptosis in the pathogenesis and treatment of disease. Science267: 1456—1462.
37.
Ward JM ( 1984). Morphology of potential preneoplastichepatocyte lesions and liver tumors in mice and a comparison with other species. In Mouse Liver Neoplasia: Current Perspectives (Popp JA Ed.), Hemisphere Publishing Corporation, Washington, DC, pp 1—26.
38.
Weghorst CM, Pereira MA, Klaunig JE (1989). Strain differences in hepatic tumor promotion by phenobarbital in diethylnitrosamine-and diethylnitrosamine-initiated infant male mice. Carcinogenesis10(8): 1409—1412.
39.
Zerban H., Radig S., Kopp-Schneider A., Bannasch P. (1994). Cell proliferation and cell death (apoptosis) in hepatic preneoplasia and neoplasia are closely related to phenotypic cellular diversity and instability. Carcinogenesis15(11): 2467—2473.
